Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.9100 (-7.12%) ($12.8300 - $13.9100) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.76% (three month average) | RSI | 23 | Latest Price | $12.9100(-7.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.38% in a week (0% probabilities). VIXM(-31%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.38% (StdDev 6.76%) | Hourly BBV | 0 () | Intraday Trend | -6.2% | | | |
|
Resistance Level | $14.2 | 5 Day Moving Average | $13.69(-5.7%) | 10 Day Moving Average | $13.7(-5.77%) | 20 Day Moving Average | $14.2(-9.08%) | To recent high | -16.7% | To recent low | 63% | Market Cap | $959m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |